1.Significance of determination of serum xanthine oxidase and lipid peroxidation indexes in acute organophosphorus poisoning.
Juan-wen ZHANG ; Guo-cai LV ; Yu-qin JIN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2008;26(4):239-240
Acute Disease
;
Adult
;
Aged
;
Female
;
Humans
;
Lipid Peroxidation
;
Male
;
Malondialdehyde
;
blood
;
Middle Aged
;
Organophosphate Poisoning
;
Oxidative Stress
;
Superoxide Dismutase
;
blood
;
Xanthine Oxidase
;
blood
;
Young Adult
2.Significance of detection of serum oxidant function in patients with silicosis.
Guo-Cai LÜ ; Jin-Mei YAO ; Juan-Wen ZHANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2010;28(1):52-53
Aged
;
Case-Control Studies
;
Humans
;
Male
;
Malondialdehyde
;
metabolism
;
Middle Aged
;
Oxidation-Reduction
;
Serum
;
metabolism
;
Silicosis
;
blood
;
Superoxide Dismutase
;
metabolism
4.Change of activity of serum paraoxonase in patients with acute organophosphorus poisoning.
Juan-wen ZHANG ; Guo-cai LV ; Yu-qin JIN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2007;25(10):610-611
Acute Disease
;
Adult
;
Aged
;
Aryldialkylphosphatase
;
blood
;
Female
;
Humans
;
Male
;
Middle Aged
;
Organophosphate Poisoning
;
Young Adult
5.Expression and clinical significance of serum chemokines in patients with paraquat poisoning.
Juan-Wen ZHANG ; Jun-Ling HE ; Guo-Cai LV
Chinese Journal of Industrial Hygiene and Occupational Diseases 2009;27(6):369-370
Acute Disease
;
Adult
;
Aged
;
Chemokines
;
blood
;
Female
;
Humans
;
Male
;
Middle Aged
;
Paraquat
;
poisoning
;
Prognosis
;
Young Adult
6.APPLICATION OF TRICKLING FILTERS IN TREATMENT OF WASTEWATER FROM GAS-GENERATING WITH HEAVY OIL
Guo-Qu ZENG ; Mei-Ying XU ; Yong-Hua LUO ; Wen-Juan CAI ; Guo-Ping SUN ;
Microbiology 1992;0(04):-
A research combined trickling filter system and active sludge aeration system was applied in the treatment of industrial wastewater from gas-generating with heavy oil. The wastewater contained both high contents of NH+4-N and mixed hydrocarbons including various PAHs. Its BOD5/COD ratio was less than 0.3 and belongs to recalcitrant, toxic wastewater. The results showed a touch-growth biofilms system was formed on the porous packing material and it played a key role in the decrease of toxicity of the influent. It could also improve the biodegradability of the wastewater.
7.Changes of mechanical pain threshold in rats with experimental autoimmune prostatitis.
Guo-Hong SONG ; Tulahong AISIKAER ; Li-Juan HE ; Saimaiti JULAITI ; Qiu-Mei ZHANG ; Wen-Yu LI
National Journal of Andrology 2014;20(6):490-494
OBJECTIVETo observe the changes of the mechanical pain threshold in the rat model of autoimmune prostatitis, explore the mechanism of autoimmune prostatitis pain and offer some animal experimental evidence for the drug therapy of the condition.
METHODSTwenty male Wistar rats weighing 180 - 220 g were divided into a model and a control group. The autoimmune prostatitis model was established by subcutaneous injection of an extract of male rat prostate glands (RPG) at 60 mg/ml in Freund's complete adjuvant (FCA) and pertussis-diphtheria-tetanus vaccine at 0 and 30 days, respectively. Mechanical tactile hyperalgesia was measured once a week using Von Frey Filaments from the beginning of the study. At 8 weeks after modeling, the rats were sacrificed and the prostate tissues harvested for observation of histomorphological changes by HE staining.
RESULTSHE staining revealed different degrees of benign prostatitis in the model rats. Compared with the controls, the mechanical pain threshold in the model rats was significantly decreased with the increased time of modeling, from (65.52 +/- 6.27) g at 0 week to (23.67 +/- 4.09) g at 8 weeks (P < 0.01). Statistically significant differences were found in the variation trend at different time points between the two groups (P < 0.01).
CONCLUSIONAutoimmune prostatitis models were successfully established in rats and hyperalgesia was induced after modeling.
Animals ; Autoimmune Diseases ; physiopathology ; Disease Models, Animal ; Male ; Pain Threshold ; physiology ; Prostatitis ; immunology ; physiopathology ; Rats ; Rats, Wistar
8.Effect of ginsenoside Rb1 in ameliorating insulin resistance and ectopic fat deposition in obese mice induced by high fat diet.
Wen-Bin SHANG ; Xi-Zhong YU ; Guo-Qiang WANG ; Juan ZHAO
China Journal of Chinese Materia Medica 2013;38(23):4119-4123
Ginsenoside Rb1 is an active component in ginseng. Previous in vitro experiments showed that ginsenoside Rb1, could inhibit lipolysis and promote glucose transporter in adipocytes. This study focused on the effect of ginsenoside Rb1 in insulin resistance and ectopic fat deposit in obese mice induced by high fat diet and its molecular mechanism. Obese male C57/L mice induced by high fat diet were randomly divided into the diet-induced obesity group (DIO group), the ginsenoside Rb1 group (Rb1 group) and the rosiglitazone group (Rog group), and continuously fed with high fat diet. In addition, male C57/L mice fed with normal diet were selected as the normal group (NC group). Mice in Rb1 group and Rog groups were intraperitoneally injected with ginsenoside Rb1 and rosiglitazone with the dosage of 20 mg x kg(-1) and 10 mg x kg(-1), respectively. NC and DIO groups were intraperitoneally injected with the same amount of saline. Two weeks later, the intraperitoneal glucose tolerance test (IPGTT) was performed. Three days later, the mice were killed, and their serum samples were collected to detect insulin and free fatty acid (FFA). Their livers were weighed to examine the triglyceride content, and a pathological detection was performed. Epididymal adipose tissues were weighed, and PDE3B, HSL and perilipin were detected by Western blotting. The results showed that the treatment with ginsenoside Rb1 for two weeks could improve the glucose tolerance of obese mice. Except for 0-120 min, the areas under the glucose tolerance curve (0-30 min, 0-60 min and 0-90 min) in the Rb1 group were less than that in the DIO group (P < 0.05, n = 5), with a much lower HOMA-IR (P < 0.05, n = 5). The fat level of obese mice was significantly reduced by Rbl (P < 0.05, n = 5), and so were liver weight/weight (P < 0.05, n = 8). The increased serum FFA of obese mice declined after the treatment of Rb1 (P < 0.05, n = 8). Rb1 could partially recover the expression of perilipin in adipose tissues, but without obvious change in the expressions of PDE3B and HSL and the phosphorylated activation. The above findings indicated that ginsenoside Rb1 could reduce the release of FFA and alleviate the ectopic deposit of triglyceride by up-regulating the expression of perilipin in adipose tissue, which may be one of its mechanisms for improving the insulin resistance and abnormal glucose metabolism of organisms.
Adipose Tissue
;
drug effects
;
pathology
;
Animals
;
Body Weight
;
drug effects
;
Diet, High-Fat
;
adverse effects
;
Dose-Response Relationship, Drug
;
Fatty Acids, Nonesterified
;
blood
;
Gene Expression Regulation
;
drug effects
;
Ginsenosides
;
pharmacology
;
Glucose Tolerance Test
;
Insulin
;
blood
;
Insulin Resistance
;
Liver
;
drug effects
;
metabolism
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Obesity
;
blood
;
etiology
;
metabolism
;
pathology
;
Organ Size
;
drug effects
;
Triglycerides
;
metabolism
9.Correlative studies on uPAR receptor mRNA expressions with vascular endothelial growth factor, microvessel density, progression and survival time of gastric carcinomas.
Zhong-sheng ZHAO ; Guo-qing RU ; Jie MA ; Wen-juan XU ; Zhong MENG
Chinese Journal of Pathology 2005;34(5):306-307
Adenocarcinoma
;
blood supply
;
metabolism
;
mortality
;
secondary
;
Adult
;
Aged
;
Female
;
Humans
;
Lymphatic Metastasis
;
Male
;
Microcirculation
;
Middle Aged
;
Neovascularization, Pathologic
;
metabolism
;
pathology
;
Prognosis
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Receptors, Cell Surface
;
biosynthesis
;
genetics
;
Receptors, Urokinase Plasminogen Activator
;
Stomach Neoplasms
;
blood supply
;
metabolism
;
mortality
;
pathology
;
Survival Rate
;
Vascular Endothelial Growth Factor A
;
metabolism
10.Pharmaceutical Care for One Case of Renal Transplantation Recipient with Pulmonary Infection
Guiping GUO ; Yao LU ; Xiangduan LIU ; Xiaoliang QIAN ; Juan BAI ; Aidong WEN ; Yin WU
China Pharmacist 2015;(11):1928-1930
Objective:To provide some thoughts for pharmaceutical treatment and care for the patients with pulmonary infection af-ter renal transplantation. Methods:Clinical pharmacists participated the whole treatment process of one case of pulmonary infection af-ter renal transplantation. According to the literatures combined with medical history, clinical symptoms and lab results, the drug treat-ment process of the patient was analyzed, and the key points of the optimized pharmaceutical care were summarized. Results: The pharmaceutical care included the dose adjustment of immunosuppressants at the early phase of the disease and after the improvement of clinical symptoms, attention paid to the interactions between multiple anti-infective drugs and immunosuppressive agents, dosage ad-justment based on the renal function of the patient, monitoring adverse drug reactions and drawing up personalized regimen. Conclu-sion:Through comprehensive medication monitoring, clinical pharmacists can help physicians develop timely and effective treatment programs and provide professional and effective pharmaceutical care for patients.